首页 | 本学科首页   官方微博 | 高级检索  
     


Characterization of estrogen quinone-derived protein adducts and their identification in human serum albumin derived from breast cancer patients and healthy controls
Authors:Chen Dar-Ren  Chen Shou-Tung  Wang Tzu-Wen  Tsai Chen-His  Wei Hz-Han  Chen Guan-Jie  Yang Tsung-Chou  Lin Che  Lin Po-Hsiung
Affiliation:a Comprehensive Breast Cancer Center, Changhua Christian Hospital, Changhua, Taiwan
b Department of Environmental Engineering, National Chung Hsing University, 250 Kuo Kuang Road, Taichung 402, Taiwan
Abstract:Both 17β-estradiol-2,3-quinone (E2-2,3-Q) and 17β-estradiol-3,4-quinone (E2-3,4-Q) are reactive metabolites of estrogen that are thought to be responsible for the estrogen-induced genotoxicity. The aim of this study was to establish a methodology to analyze estrogen quinone-derived protein adducts and to measure the background levels of these adducts in human serum albumin (Alb) derived from female blood donors in Taiwan. Results from in vitro experiments confirmed that the production of estrogen quinone-derived adducts on serum Alb increased with increased concentration of estrogen quinones. Time-course experiments suggested that both E2-2,3-Q- and E2-3,4-Q-derived adducts rapidly reached maximum values at 10 min mark and remained constant thereafter for up to 24 h. Additionally, with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) pretreatment, the production of estrogen quinone-derived protein adducts was detected in human MCF-7 breast cancer cells exposed to estrogen. Co-treatment of a catechol-O-methyl transferase inhibitor further enhanced the production of estrogen quinone-derived adducts in all cases. When we investigated the levels of estrogen quinone-derived adducts in human serum Alb, cysteinyl adducts of E2-2,3-Q-1-S-Alb, E2-2,3-Q-4-S-Alb, and E2-3,4-Q-2-S-Alb were detected in all healthy female controls (n = 10) with median levels at 147 (range 14.1-533), 197 (range 30.0-777), and 65.6 (range 17.6-1360) (pmol/g), respectively. We noticed that levels of E2-2,3-Q-derived adducts were 2-fold greater than those of E2-3,4-Q-2-S-Alb in controls whereas levels of E2-3,4-Q-2-S-Alb were 2-fold higher than those of E2-2,3-Q-derived adducts in patients (n = 20). Additionally, levels of E2-2,3-Q-4-S-Alb correlated significantly with those of E2-3,4-Q-2-S-Alb (correlation coefficient r = 0.684-0.850, p < 0.05). Overall, we conclude that cumulative body burden of E2-3,4-Q is a significant predictor of breast cancer.
Keywords:AhR, arylhydrocarbon receptor   Alb, albumin   COMT, catechol-O-methyl transferase   Cp, cytoplasmic proteins   CYP1A1, cytochrome P450 1A1   CYP1B1, cytochrome P450 1B1   DMSO, dimethyl sulfoxide   E2, 17β-estradiol   E2-2,3-Q, 17β-estradiol-2,3-quinone   E2-3,4-Q, 1,7β-estradiol-3,4-quinone   E2-2,3-Q-1-NAC and E2-2,3-Q-4-NAC, reaction products of E2-2,3-Q with N-acetyl-  smallcaps"  >l-cysteine   E2-3,4-Q-2-NAC, reaction products of E2-3,4-Q with N-acetyl-  smallcaps"  >l-cysteine   E2-2,3-Q-1-S-Alb and E2-2,3-Q-1-S-Alb, adducts resulting from reaction of E2-2,3-Q with Alb   E2-3,4-Q-2-S-Alb, adducts resulting from reaction of E2-3,4-Q with Alb   E2-2,3-Q-1-S-Hb and E2-2,3-Q-4-S-Hb, adducts resulting from reaction of E2-2,3-Q with Hb   E2-3,4-Q-2-S-Hb, adducts resulting from reaction of E2-3,4-Q with Hb   E2-2,3-Q-1-S-TFA and E2-2,3-Q-4-S-TFA, trifluoroacetyl derivative of E2-2,3-Q adduct after adduct cleavage   E2-3,4-Q-2-S-TFA, trifluoroacetyl derivatives of E2-3,4-Q adduct after adduct cleavage   EI, electron impact   ERα, estrogen receptors-alpha   GC-MS, gas chromatograph and mass spectrometer   [2H5]-E2, E2-2, 4, 16, 16, 17-d5 ([2H5]-E2)   Hb, hemoglobin   HPLC, high performance liquid chromatography   MSA, methanesulfonic acid   MT assay, methanesulfonic acid and trifluoroacetic acid anhydride assay   NAC, N-acetyl-  smallcaps"  >l-cysteine   NICI, negative ion chemical ionization   ROS, reactive oxygen species   SD, standard deviation   TCDD, 2,3,7,8-tetrachlorodibenzo-p-dioxin   TFA, trifluoroacetyl   TFAA, trifluoroacetic acid anhydride
本文献已被 ScienceDirect PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号